Materials
N-Fmoc-protected L-amino acids were purchased from Merck Millipore. N,N-dimethylformamide (DMF), piperidine 20% v/v in DMF and acetic anhydride were purchased from Sigma-Aldrich®. H-L-Cys(Trt)-2-chlorotrityl resin (0.49 mmol/g) was bought from AGTC Bio Products Ltd. N,N-diisopropylethylamine (DIPEA), triisopropylsilane (TIPS), 1,2-ethanedithiol (EDT) and trifluoroacetic acid (TFA) were bought from Alfa Aesar®. N,N,N',N'-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU) was purchased from Carbosynth Ltd. All other chemicals were purchased from Fisher Scientific UK Ltd. and were used without further purification.
Instrumentation
NMR data was acquired on a Bruker Avance III operating at 400 MHz and fitted with a 5 mm DUL probe ( 1 H/ 13 C). MS spectra were obtained on a Xevo ® G2-XS ToF (Waters) from electrospray ionisation (ESI) and time-of-flight (TOF) measurement in positive ion mode. High-resolution MS data was calculated by comparison with leucine-enkephalin as internal standard. Reverse phase (RP) HPLC analysis was run through a Kinetex ® C18-EVO column (Phenomenex ® ): 5 μm, 100 Å, 250x4.60 mm. A gradient from 3 to 20% of (CH3CN + 0.05% TFA) in (H2O + 0.05% TFA) was used at 1 mL/min. The column was maintained at 35°C and UV-VIS detection was set at 210 nm. Circular dichroism spectra were recorded in 1 mm path length quartz cuvettes on a Jasco J-715 spectropolarimeter. The observed ellipticity in millidegrees was converted into mean residue ellipticity and it is reported in units of degree⋅dmol . [1] 3. Peptide synthesis 500 mg of H-L-Cys(Trt)-2-chlorotrityl resin (0.245 mmol) were swollen in 5 mL of DMF for 30 minutes. Then, solutions of Fmoc-L-amino acid (3 eq), HBTU (2.8 eq) and DIPEA (2.8 eq) in DMF were added to a final volume of 5 mL. The reaction mixture was rolled for 1 h at room temperature, after which a negative chloranil test [2] indicated the reaction had gone to completion. The N-terminal Fmoc protecting group was removed by washing the resin with 5 mL of piperidine 20% v/v in DMF during 10 minutes. A positive chloranil test confirmed the removal of the Fmoc group, and the previous steps were repeated to couple all amino acids in the sequence. Following the coupling of the last amino acid, the Fmoc group was removed and the terminal amine of the peptide was capped by reacting with 5 mL of acetic anhydride:DIPEA:DMF (1:1:3) for 1 h at room temperature. Then, the resin was thoroughly washed with DMF and diethyl ether, and the peptide was cleaved from the resin with 5 mL of a mixture containing TFA (80%), TIPS (8%) and EDT (12%) for 2 h. After this time, the solution was concentrated under argon and precipitated in chilled diethyl ether:hexane (1:4). Finally, the suspension was centrifuged and the pellets were washed twice with diethyl ether:hexane (1:4), dissolved in water and freeze-dried. Peptides that showed impurities by 1 H-NMR (e.g. trityl protecting groups) were further purified by dissolving the material in 2 mL of a 10% TIPS solution in TFA and precipitating in chilled diethyl ether:hexane (1:4), to be then centrifuged and freeze-dried as explained above. Peptide purity was determined by HPLC.
Peptide characterisation
The synthesis and characterisation of peptides P1SH (Ac-CEGLAEC-OH) and P5 (H2N-LAE-OH) has been previously reported. [3] P2SH, Ac-CEEGLAEEC-OH (154.8 mg, 62% yield) C (right) NMR spectra (400 MHz, DMSO-d6). Bottom: Mass spectrum (left) and RP-HPLC chromatogram (right). 
Enzymatic degradation of peptides
In this experiment several controls have been performed to ensure that the observed increase in fluorescence is related to the elastase-mediated hydrolysis of the peptides.
• Succinyl casein (SC) is a positive control for enzymatic activity. This protein is degraded by most proteases, and an increase in fluorescence for SC in the presence of elastases indicates that these enzymes are active.
• All substrates (e.g. peptide, SC) have been incubated for 4 h under assay conditions in the absence of the elastases and the fluorescence observed is represented by black bars. This includes buffer alone (black bar now labelled control).
• P5, a peptide with a sequence that matches the hydrolysis product of one of our previously reported peptides, [4] was incubated in the absence of elastase and the fluorescence obtained was associated to 100% hydrolysis.
Figure S4
Emission intensity (λexc 355 nm, λem 460 nm) of fluorescamine conjugates for buffer and enzymes (controls), succinyl casein (SC, a control for enzymatic activity) in the absence and presence of enzymes, peptides P1-4SH in the absence and presence of enzymes, and the peptide H2N-LA-E-OH (P5, a control to normalise fluorescence intensity). All samples were incubated for 4 hours. n = 3, mean ± SD. 
